Выходит 6 номеров в год
ISSN Печать: 0743-4863
ISSN Онлайн: 2162-660X
Indexed in
Dry Powder Nasal Vaccines as an Alternative to Needle-Based Delivery
Краткое описание
Drug delivery to the nasal cavity has been achieved using a variety of systems. Dry powder vaccines offer the advantages of chemical and physical stability in comparison to liquid formulations. An intranasal vaccine can elicit both a local and systemic immune response. Mucoadhesive compounds can extend the residence time for powder formulations on the nasal mucosa, potentially increasing the immune response. Manufacture and characterization of a formulation containing particles of a dry powder vaccine are discussed.
-
Balducci Anna Giulia, Ferraro Luca, Bortolotti Fabrizio, Nastruzzi Claudio, Colombo Paolo, Sonvico Fabio, Russo Paola, Colombo Gaia, Antidiuretic effect of desmopressin chimera agglomerates by nasal administration in rats, International Journal of Pharmaceutics, 440, 2, 2013. Crossref
-
Velasquez Lissette S., Shira Samantha, Berta Alice N., Kilbourne Jacquelyn, Medi Babu M., Tizard Ian, Ni Yawei, Arntzen Charles J., Herbst-Kralovetz Melissa M., Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine, Vaccine, 29, 32, 2011. Crossref
-
Michel J., Moreddu E., Varoquaux A., Dessi P., Esplorazioni fisiche e funzionali delle fosse nasali, EMC - Otorinolaringoiatria, 13, 3, 2014. Crossref
-
Watts Peter J., Smith Alan, Re-formulating drugs and vaccines for intranasal delivery: maximum benefits for minimum risks?, Drug Discovery Today, 16, 1-2, 2011. Crossref
-
Levine Myron M., “IDEAL” vaccines for resource poor settings, Vaccine, 29, 2011. Crossref
-
Tataru G., Popa M., Costin D., Desbrieres J., Microparticles based on natural and synthetic polymers for ophthalmic applications, Journal of Biomedical Materials Research Part A, 100A, 5, 2012. Crossref
-
Ramvikas M., Arumugam M., Chakrabarti S.R., Jaganathan K.S., Nasal Vaccine Delivery, in Micro and Nanotechnology in Vaccine Development, 2017. Crossref
-
Scherließ Regina, Nasal Administration of Vaccines, in Subunit Vaccine Delivery, 2015. Crossref
-
Hickey Anthony J., Staats Herman, Roy Chad J., Powell Kenneth G., Sullivan Vince, Rothrock Ginger, Sayes Christie M., Nasal Dry Powder Vaccine Delivery Technology, in Molecular Vaccines, 2014. Crossref
-
Romani N., Flacher V., Tripp C. H., Sparber F., Ebner S., Stoitzner P., Targeting Skin Dendritic Cells to Improve Intradermal Vaccination, in Intradermal Immunization, 351, 2011. Crossref
-
Hellfritzsch , Scherließ , Mucosal Vaccination via the Respiratory Tract, Pharmaceutics, 11, 8, 2019. Crossref
-
Sánchez-López Edwin F., Corigliano Mariana G., Oliferuk Sonia, Ramos-Duarte Victor A., Rivera Maximiliano, Mendoza-Morales Luisa F., Angel Sergio O., Sander Valeria A., Clemente Marina, Oral Immunization With a Plant HSP90-SAG1 Fusion Protein Produced in Tobacco Elicits Strong Immune Responses and Reduces Cyst Number and Clinical Signs of Toxoplasmosis in Mice, Frontiers in Plant Science, 12, 2021. Crossref
-
Pilicheva Bissera, Boyuklieva Radka, Can the Nasal Cavity Help Tackle COVID-19?, Pharmaceutics, 13, 10, 2021. Crossref
-
Scherließ Regina, Nasal formulations for drug administration and characterization of nasal preparations in drug delivery, Therapeutic Delivery, 11, 3, 2020. Crossref
-
Zainutdinov S. S., Sivolobova G. F., Loktev V. B., Kochneva G. V., Mucosal immunity and vaccines against viral infections, Problems of Virology, 66, 6, 2022. Crossref
-
Tai Junhu, Han Munsoo, Lee Dabin, Park Il-Ho, Lee Sang Hag, Kim Tae Hoon, Different Methods and Formulations of Drugs and Vaccines for Nasal Administration, Pharmaceutics, 14, 5, 2022. Crossref
-
Al-Nemrawi Nusaiba K., Darweesh Ruba S., Al-shriem Lubna A., Al-Qawasmi Farah S., Emran Sereen O., Khafajah Areej S., Abu-Dalo Muna A., Polymeric Nanoparticles for Inhaled Vaccines, Polymers, 14, 20, 2022. Crossref